Traders work the floor of Dow Jones at the closing time of the New York Stock Exchange.
Bryan R. Smith | AFP | Getty Images
Check out mid-day headline companies:
Home Depot – Shares of Home Depot rose more than 4% on Tuesday after the company reported higher earnings per share than analysts expected. The Atlanta-based retailer earned $ 3.17 in adjusted earnings per share in the last quarter, topping $ 3.08 estimated by Refinitive. The company missed revenue expectations for the quarter and lower sales guidance for the entire year, citing trade considerations and weakening timber prices.
Beyond Meat ̵
Medtronic – Medtronic shares climbed more than 4% based on strong quarterly results. The medical device manufacturer made a profit of $ 1.26 per share on revenue of $ 7.493 billion. Analysts polled by Refinitive expected earnings per share of $ 1.18 for a turnover of $ 7.336 billion. Medtronic's sales exceeded estimates in all divisions, including cardiovascular devices.
Kohl's – Kohl's shares fell more than 5% after reporting weaker sales than comparable stores in the second quarter. The retailer's comparable store sales fell by 2.9% in the second quarter. Analysts polled by Refinitive expected a 2.5% decline.
TJX Companies – TJX shares fell 1.4% after announcing weaker-than-expected earnings for the second quarter. The company's revenue was $ 9.782 billion for the quarter, under a Refinitive estimate of $ 9.901 billion. Sales of the same store, an important calculation for retailers, rose 2% in the quarter, below an estimate of 3%. The company reported weaker sales in all its segments except international.
Madison Square Garden – Shares of Madison Square Garden plunged more than 9% – heading for its worst day ever – after the sports and entertainment company missed analyst expectations on the top and bottom lines of the fourth quarter. The company reported losses of $ 3.08 per share of $ 263.6 million in revenue. Analysts expected a $ 2.61 loss per share of $ 270.1 million in revenue, according to Refinitive. The company's losses expanded compared to the same period last year, which partly attributed to increased personnel costs and expenses related to a proposed spin-off of its sports activities.
Sarepta Therapeutics – Drugmaker shares fell more than 16% after the Food and Drug Administration rejected a new drug application seeking rapid approval of golodirsen, a drug aimed at treating Duchenne muscular dystrophy.
AbbVie – An analyst at Piper Jaffray upgraded AbbVie to overweight from neutral, citing "immediate" earnings costs and cost reductions that will come from the company's acquisition of Allergan. AbbVie shares rose 0.8%.
HP Inc – HP Inc was downgraded to neutral from purchases, highlighting headwinds to its commercial PC business following the Windows 10 update. The stock traded 1% lower.
—CNBC's Jesse Pound and Elizabeth Myong contributed to this report.